Nexus Surgical Reports FY26 Revenue Growth and Leadership Transition

Revenue: Rs 7.89 crore | Net Profit: Rs 0.73 crore

Reader Takeaway: Strong top-line growth and debt-free status contrast with a minor SEBI compliance oversight in reporting.

What just happened

Nexus Surgical and Medicare Limited has released its financial performance for the year ending March 31, 2026. The company recorded a significant increase in total revenue, rising to Rs 7.89 crore from Rs 5.72 crore in the previous fiscal year. Net profit after tax also showed positive momentum, reaching Rs 0.73 crore, up from Rs 0.49 crore a year earlier.

Board and Management Changes

Effective September 2, 2026, the company underwent a major leadership shuffle. Anish More has been appointed as Managing Director for a three-year tenure. Ram Swaroop Joshi has stepped down as Managing Director and transitioned to the role of Promoter Non-Executive Director. Furthermore, Ashish Durgaprasad Mishra joined as an Independent Director for five years, and Neha Kailash Bhageria was re-appointed as an Independent Woman Director for a second five-year term.

Compliance and Auditor Notes

The Secretarial Audit Report for FY 2025-26 identified an administrative lapse. The company failed to publish quarterly financial results in newspapers as mandated by Regulation 47 of SEBI (LODR) Regulations. Management has categorized this as an inadvertent administrative oversight.

Business Overview

Nexus Surgical operates an asset-light model focused on trading medical essentials, including disposable syringes and sterile storage pouches. The company currently maintains a debt-free balance sheet with no subsidiaries or joint ventures, keeping its operations centralized.